Displaying 1–5 of 5 results for Dean Erhardt, President and CEO, D2 Consulting

Sort By Relevance Sort By Date

What the FDA’s Plans to Boost Drug Competition Could Mean for Pharma

(Article)

The agency is considering various strategies to get pricing under control. But do these ideas factor in critical drug pricing trends?

The ‘Blueprint’ to Control Drug Prices: A Quick Guide for Manufacturers

(Article)

With regulatory measures related to drug prices and rebates supported by both sides of Congress, manufacturers should be prepared for new challenges.

Sort By Relevance Sort By Date